Rumin8
Caroline Heller possesses extensive experience in the animal health sector, currently serving as a Member at VANE and the Head of Animal Health & Business Development at Rumin8. In addition to their role as an Independent Consultant at AnPharm Consulting, Caroline advises various animal health start-ups and financial sector clients on investment and acquisition strategies. Prior experience includes leadership positions at Cargill, Zoetis, and Pfizer Animal Health, where Caroline drove marketing initiatives, pipeline strategy, and commercial development for successful product launches and market growth. Educational credentials include an MBA from Columbia Business School, an MA in International Relations from Johns Hopkins SAIS, a DVM from Tufts University, and a BS in Biology from the University of North Carolina at Chapel Hill.
This person is not in any offices
Rumin8
Rumin8 is tackling one of the biggest contributors to climate change: methane emissions from livestock. The digestive process of beef and dairy cattle accounts for a full 3.7% of all greenhouse gas emissions, a huge contribution from a single source. With billions of people around the world relying on animal proteins as part of their daily diet,eliminating livestock methane production is a powerful lever in the quest toward a climate-optimal future.Rumin8 has invented a technology that has been shown to reduce the emissions from cattle by up to 95%. Our technology productizes the anti-methane compounds that occur naturally in plants and turns them into dietary supplements for livestock. The results are a reduction in methane emissions by up to 95%, an increase in the efficiency of the animal’s digestive systems, and more energy for the animal to growThe company is on a mission to decarbonize hundreds of millions of cattle around the world so the global food system can take a giant step forward.